The dynamics of oxidative stress markers in patients with asthma exacerbation during the course of liposome admission Source: Annual Congress 2009 - New drugs for airways disease Year: 2009
Monitoring antioxidant enzyme activity in patients with COPD exacerbations Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Impact of physical activity level on symptomatology and functionality during an acute exacerbation in COPD patients. Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease Year: 2018
Lipid profile changes in asthma patients at acute attack and stable period Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
Active oxygen forms and antioxidant blood status in patients with community acquired pneumonia and its combination with COPD Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017
Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
Proteolytic activity of sputum and serum in patients with COPD exacerbation in dependence on smoking Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003
Erythrocyte and blood plasma antioxidant system status during the community-acquired pneumonia acute period Source: Eur Respir J 2006; 28: Suppl. 50, 1s Year: 2006
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Decrease of physical activity in patients with COPD in the course of the disease Source: Annual Congress 2012 - The best abstracts in chronic care Year: 2012
The interrelationship of the inflammatory markers in blood and sputum of stable COPD patients before and after treatment with inhaled steroids and N-acetylcysteine Source: Eur Respir J 2003; 22: Suppl. 45, 281s Year: 2003
The effect of methylxanthine, corticosteroid, and N -acetylcystein on plasma oxidant/antioxidant levels in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 215s Year: 2001
Plasma biomarkers and response to therapy at exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007
A preliminary study to determine the effects of nebulised salbutamol on blood glucose levels during an acute asthma exacerbation. Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019
Changes in physical activity and sleep duration following hospitalisation with acute exacerbation of COPD Source: Annual Congress 2012 - The latest insights in chronic care Year: 2012
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Does the duration of symptoms pre admission influence the clinical course of the exacerbation in COPD? Source: Eur Respir J 2004; 24: Suppl. 48, 15s Year: 2004